{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:33:53Z","timestamp":1790354033435,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T00:00:00Z","timestamp":1588118400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T00:00:00Z","timestamp":1588118400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ital J Pediatr"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Although disseminated intravascular coagulation (DIC) is a critical disease, there is few gold standard interventions in neonatal medicine. The aim of this study is to reveal factors affecting neonatal DIC at birth and to assess the effectiveness of rTM and FFP for DIC in neonates at birth.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We retrospectively evaluated DIC score on the first day of life in neonates with underlying conditions associated with DIC. DIC in neonates was diagnosed according to Japan Society of Obstetrical, Gynecological &amp; Neonatal Hematology 2016 neonatal DIC criteria.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Comparing neonates with DIC scores of \u22653 (<jats:italic>n<\/jats:italic>\u2009=\u2009103) to those &lt;\u20093 (<jats:italic>n<\/jats:italic>\u2009=\u2009263), SGA, birth asphyxia, low Apgar score, hemangioma, hydrops, PIH, and PA were statistically increased. Among 55 neonates underwent DIC treatment, 53 had birth asphyxia and 12 had intraventricular hemorrhage. Forty-one neonates received FFP or a combination of FFP and antithrombin (FFP group), while 14 neonates received rTM or a combination of rTM, FFP, and antithrombin (rTM group). DIC score before treatment in the rTM group was significantly higher than in the FFP group (4.7 vs 3.6, <jats:italic>P<\/jats:italic>\u00a0&lt;\u20090.05). After treatment, DIC scores in both groups were significantly reduced on Day 1 and Day 2 (P\u2009&lt;\u20090.05).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Among various factors associated with DIC in neonates at birth, birth asphyxia is particularly significant. Furthermore, rTM in combination with FFP therapy was effective for neonatal DIC at birth.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13052-020-0815-7","type":"journal-article","created":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T19:03:17Z","timestamp":1588186997000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Risk factors and treatments for disseminated intravascular coagulation in neonates"],"prefix":"10.1186","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0138-6676","authenticated-orcid":false,"given":"Hayato","family":"Go","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Ohto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth E.","family":"Nollet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nozomi","family":"Kashiwabara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Ogasawara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Chishiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Hiruta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiri","family":"Sakuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukihiko","family":"Kawasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuaki","family":"Hosoya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,29]]},"reference":[{"issue":"1","key":"815_CR1","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/s13054-017-1808-9","volume":"21","author":"T Wada","year":"2017","unstructured":"Wada T, Gando S, Maekawa K, et al. Disseminated intravascular coagulation with increased fibrinolysis during the early phase of isolated traumatic brain injury. Crit Care. 2017;21(1):219. https:\/\/doi.org\/10.1186\/s13054-017-1808-9.","journal-title":"Crit Care"},{"issue":"1","key":"815_CR2","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13613-017-0332-z","volume":"7","author":"T Iba","year":"2017","unstructured":"Iba T, Hagiwara A, Saito D, et al. Effects of combination therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation. Ann Intensive Care. 2017;7(1):110. https:\/\/doi.org\/10.1186\/s13613-017-0332-z.","journal-title":"Ann Intensive Care"},{"key":"815_CR3","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1203\/00006450-197912000-00006","volume":"13","author":"DR Barnard","year":"1979","unstructured":"Barnard DR, Simmons MA, Hathaway WE. Coagulation studies in extremely premature infants. Pediatric Res. 1979;13:1330\u20135.","journal-title":"Pediatric Res"},{"key":"815_CR4","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1055\/s-0030-1254050","volume":"36","author":"A Veldman","year":"2010","unstructured":"Veldman A, Fischer D, Nold MF, et al. Disseminated intravascular coagulation in term and preterm neonates. Semin Thromb Hemost. 2010;36:419\u201328.","journal-title":"Semin Thromb Hemost"},{"issue":"5","key":"815_CR5","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1177\/1076029614523490","volume":"20","author":"A Shirahata","year":"2014","unstructured":"Shirahata A, Mimuro J, Takahashi H, et al. Postmarketing surveillance of recombinant human soluble Thrombomodulin (Thrombomodulin \u03b1) in pediatric patients with disseminated intravascular coagulation. Clin Appl Thromb Hemost. 2014;20(5):465\u201372.","journal-title":"Clin Appl Thromb Hemost"},{"key":"815_CR6","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1160\/TH15-12-0987","volume":"115","author":"M Hayakawa","year":"2016","unstructured":"Hayakawa M, Yamakawa K, Saito S, et al. Recombinant human soluble thrombomodulin and mortality in sepsis-induced disseminated intravascular coagulation. A multicenter retrospective study. Thrombo Haemost. 2016;115:1157\u201366.","journal-title":"Thrombo Haemost"},{"key":"815_CR7","unstructured":"Shirahata A, Takahashi Y, Ibara S, et al. Guideline of Diagnosis and Clinical Management for Neonatal DIC, 2016. Task force for establishment of neonatal DIC guideline. The Japan Society of Obstetrical, Gynecological & Neonatal Hematology 2016; 25(2):3\u201334."},{"key":"815_CR8","doi-asserted-by":"crossref","unstructured":"Go H, Ohto H, Nollet KE, et al. Perinatal factors affecting coagulation parameters at birth in preterm and term neonates: a retrospective cohort study. Am Journal of Perinatology. 2019;36(14):1464\u201370.","DOI":"10.1055\/s-0039-1677867"},{"key":"815_CR9","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1038\/jp.2011.182","volume":"32","author":"C Poralla","year":"2012","unstructured":"Poralla C, Traut C, Hertfelder HJ, et al. The coagulation system of extremely preterm infants: influence of perinatal risk factors on coagulation. J Perinatol. 2012;32:869\u201373.","journal-title":"J Perinatol"},{"key":"815_CR10","doi-asserted-by":"publisher","first-page":"F319","DOI":"10.1136\/fn.88.4.F319","volume":"88","author":"M Salonvaara","year":"2003","unstructured":"Salonvaara M, Riikonen P, Kekomaki R, et al. Effects of gestational age and prenatal in premature events on the coagulation status in premature infants. Arch Dis Child Fetal Neonatal Ed. 2003;88:F319\u201323.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"815_CR11","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s00431-013-2155-8","volume":"173","author":"A Shirahata","year":"2014","unstructured":"Shirahata A, Mimuro J, Takahashi H, et al. Recombinant soluble human thrombomodulin (thrombomodulin alfa) in the treatment of neonatal disseminated intravascular coagulation. Eur J Pediatr. 2014;173:303\u201311.","journal-title":"Eur J Pediatr"},{"key":"815_CR12","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1186\/1471-2431-14-277","volume":"14","author":"KR Forman","year":"2014","unstructured":"Forman KR, Diab Y, Wong EC, et al. Coagulopathy in newborns with hypoxic ischemic encephalopathy with therapeutic hypothermia: a retrospective case-control study. BMC Pediatr. 2014;14:277. https:\/\/doi.org\/10.1186\/1471-2431-14-277.","journal-title":"BMC Pediatr"},{"issue":"2","key":"815_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-013787","volume":"7","author":"MA Pakvasa","year":"2017","unstructured":"Pakvasa MA, Winker AM, Hamrick SE, et al. Observational study of haemostatic dysfunction and bleeding in neonates with hypoxic-ischemic encephalopathy. BMJ Open. 2017;7(2):e013787.","journal-title":"BMJ Open"},{"key":"815_CR14","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/S0140-6736(05)17946-X","volume":"365","author":"PD Gluckman","year":"2005","unstructured":"Gluckman PD, Wyatt JS, Azzopardi D, et al. Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre randomised trial. Lancet. 2005;365:663\u201370.","journal-title":"Lancet"},{"key":"815_CR15","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1056\/NEJMcps050929","volume":"353","author":"S Shankaran","year":"2005","unstructured":"Shankaran S, Laptook AR, Ehrenkranz RA, et al. Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med. 2005;353:1574\u201384.","journal-title":"N Engl J Med"},{"key":"815_CR16","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1056\/NEJMoa0900854","volume":"361","author":"DV Azzopardi","year":"2009","unstructured":"Azzopardi DV, Strohm B, Edwards AD, et al. Moderate hypothermia to treat perinatal asphyxial encephalopathy. N Engl J Med. 2009;361:1349\u201358.","journal-title":"N Engl J Med"},{"key":"815_CR17","doi-asserted-by":"crossref","unstructured":"Riihim\u00e4ki O, Mets\u00e4ranta M, Paavonen J, et al. Placental Abruption and Child Mortality. Pediatrics. 2018;142(2). pii: e20173915.","DOI":"10.1542\/peds.2017-3915"},{"issue":"24","key":"815_CR18","doi-asserted-by":"publisher","first-page":"4096","DOI":"10.3109\/14767058.2016.1159674","volume":"29","author":"S Chumpathong","year":"2016","unstructured":"Chumpathong S, Sirthanetbhol S, Salakij B, et al. Maternal and neonatal outcomes in women with severe pre-eclampsia undergoing cesarean section: a 10-year retrospective from a single tertiary care center: anesthetic point of view. J Matern Fetal Neonatal Med. 2016;29(24):4096\u2013100.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"5","key":"815_CR19","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1055\/s-2007-996040","volume":"24","author":"S Suzuki","year":"1998","unstructured":"Suzuki S, Morishita S. Hypercoagulability and DIC in high-risk infants. Semin Thromb Hemost. 1998;24(5):463\u20136.","journal-title":"Semin Thromb Hemost"},{"key":"815_CR20","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1002\/ajh.2830430306","volume":"43","author":"H Wada","year":"1993","unstructured":"Wada H, Minamikawa K, Wakita Y, et al. Hemostatic study before onset of disseminated intravascular coagulation. Am J Hematol. 1993;43:190\u20134.","journal-title":"Am J Hematol"},{"issue":"2","key":"815_CR21","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.thromres.2011.02.015","volume":"128","author":"K Kawasugi","year":"2011","unstructured":"Kawasugi K, Wada H, Hatada T, et al. Japanese Society of Thrombosis Hemostasis\/DIC subcommittee. Prospective evaluation of hemostatic abnormalities in overt DIC due to various underlying disease. Thromb Res. 2011 Aug;128(2):186\u201390.","journal-title":"Thromb Res"},{"issue":"4","key":"815_CR22","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.tmrv.2016.07.001","volume":"30","author":"K Ak","year":"2016","unstructured":"Ak K, Stanworth SJ. Neonatal plasma transfusion: an evidence-based review. Transfus Med Rev. 2016;30(4):174\u201382.","journal-title":"Transfus Med Rev"},{"issue":"Suppl 1","key":"815_CR23","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3109\/14767058.2011.607677","volume":"24","author":"M Motta","year":"2011","unstructured":"Motta M, Del Vecchio A, Radicioni M. Clinical use of fresh-frozen plasma and cryoprecipitate in neonatal intensive care unit. J Matern Fetal Neonatal Med. 2011;24(Suppl 1):129\u201331.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"815_CR24","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jcrc.2016.06.008","volume":"36","author":"N Yasuda","year":"2016","unstructured":"Yasuda N, Goto K, Ohchi Y, et al. The efficacy safety antithrombin and recombinant human thrombomodulin combination therapy in patients with severe sepsis and disseminated intravascular coagulation. J Crit Care. 2016;36:29\u201334.","journal-title":"J Crit Care"},{"issue":"2","key":"815_CR25","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s12288-016-0683-x","volume":"33","author":"P Mitra","year":"2017","unstructured":"Mitra P, Guha D, Nag SS, et al. Role of plasma fibrinogen in diagnosis and prediction of short term outcome in neonatal Sepsis. Indian J Hematol Blood Transfus. 2017;33(2):195\u20139.","journal-title":"Indian J Hematol Blood Transfus"},{"key":"815_CR26","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1055\/s-0038-1649835","volume":"74","author":"H Wada","year":"1995","unstructured":"Wada H, Wakita Y, Nakase T, et al. Outcome of disseminated intravascular coagulation in relation to the score when treatment was begun. Thromb Haemost. 1995;74:848\u201352.","journal-title":"Thromb Haemost"},{"issue":"3","key":"815_CR27","first-page":"419","volume":"90","author":"TE Selim","year":"2005","unstructured":"Selim TE, Ghoneim HR, Khashaba MT, et al. Plasma soluble fibrin monomer complex is a useful predictor of disseminated intravascular coagulation in neonatal sepsis. Haematologica. 2005;90(3):419\u201321.","journal-title":"Haematologica."},{"key":"815_CR28","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.thromres.2015.03.007","volume":"135","author":"T Iba","year":"2015","unstructured":"Iba T, Saitoh D, Gando S, et al. The usefulness of antithrombin activity monitoring during antithrombin supplementation in patients with sepsis- associated disseminated intravascular coagulation. Thromb Res. 2015;135:897\u2013901.","journal-title":"Thromb Res"},{"key":"815_CR29","doi-asserted-by":"publisher","first-page":"R297","DOI":"10.1186\/cc13163","volume":"17","author":"S Gando","year":"2013","unstructured":"Gando S, Saitoh D, Ishikura H, et al. A randomized, controlled, multicenter trial of the effects of antithrombin on disseminated intravascular coagulation in patients with sepsis. Crit Care. 2013;17:R297.","journal-title":"Crit Care"}],"container-title":["Italian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-020-0815-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13052-020-0815-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-020-0815-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T23:54:43Z","timestamp":1619654083000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijponline.biomedcentral.com\/articles\/10.1186\/s13052-020-0815-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,29]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["815"],"URL":"https:\/\/doi.org\/10.1186\/s13052-020-0815-7","relation":{},"ISSN":["1824-7288"],"issn-type":[{"value":"1824-7288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,29]]},"assertion":[{"value":"8 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted with the approval of the Institutional Human Ethical Committee of Fukushima Medical University. An informed consent was obtained from all the subjects or guardians who participated in this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read and approved the content, and they agree to submit it for consideration for publication in the journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"54"}}